IART(Integra LifeSciences Holdings Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.54B | $1.56B | $1.54B | $1.61B | $1.64B |
| 毛利润 | $944.64M | $970.31M | $884.74M | $882.06M | $831.62M |
| 营业利润 | $197.23M | $238.92M | $111.53M | $28.41M | −$493.37M |
| 净利润 | $169.07M | $180.55M | $67.74M | −$6.94M | −$516.47M |
| 经营现金流 | $312.43M | $264.47M | $139.96M | $129.38M | $50.38M |
| 自由现金流 | $264.40M | $222.13M | $73.09M | $24.96M | −$31.05M |
| 摊薄每股收益 | $1.98 | $2.16 | $0.84 | $-0.09 | $-6.74 |